US 9321757
Heterocyclic compound
granted A61KA61K9/06A61K9/2018
Quick answer
US patent 9321757 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Apr 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K9/06, A61K9/2018, A61K9/2054, A61K9/4858